Lv3
220 积分 2025-04-12 加入
A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data
1个月前
已完结
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
1个月前
已完结
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
3个月前
已完结
Haemolysis of various mammalian erythrocytes in sodium chloride, glucose and phosphate-buffer solutions
4个月前
已完结
Point-CounterpointContext Matters: TP53 Alterations in Myeloid Neoplasms
5个月前
已关闭
Multi-Hit TP53 Mutations in Myeloid Neoplasms: Prognostic Impact of Morphologic Subtype Designation and Variant Allele Frequency
5个月前
已完结
A clinical guide to TP53 mutations in myeloid neoplasms
5个月前
已完结
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1
7个月前
已完结
Traitement des syndromes myélodysplasiques de haut risque
8个月前
已关闭
皖公网安备34019202002308
